DIEP Flap Perfusion Evaluated by DIRT and ICG-FA.

NCT ID: NCT04115995

Last Updated: 2019-10-04

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

30 participants

Study Classification

OBSERVATIONAL

Study Start Date

2019-01-16

Study Completion Date

2019-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Patients selected for DIEP breast reconstruction were examined with preoperative CTA, Doppler Ultrasound, dynamic infrared thermography (DIRT) and Indocyanin green fluorescent angiography (ICG-FA) for perforator mapping. DIRT and ICG-FA were used to evaluate perfusion of selected perforators. Following anastomoses for the DIEP flap to internal mammary vessels , patency of the anastomosis was evaluated with DIRT and ICG-FA. Recorded images from all the modules were compared.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Introduction:

'The primary aim of our study is to compare invasive and non-invasive techniques to select a dominant perforator when harvesting a DIEP-flap for autologous breast reconstruction.

The secondary aim is to compare Dynamic Infrared Thermography (DIRT) and Laser Fluorescence Angiography (LFA) of Indocyanine green (ICG) in order to see whether they could be useful in the early detection of insufficient perfusion following the microvascular anastomotic procedure in DIEP flaps.

Material and Method:

Patients selected for breast reconstruction with autologous tissue were examined with preoperative CTA and a handheld Doppler Ultrasound for perforator mapping. Thereafter visual images from same area was obtained with dynamic infraredeed thermography (DIRT) and Indocyanin green fluorescent angiography (ICG-FA) before and after dissection of the skin flap with preserved medial and lateral DIEP perforators. Reconstructed breasts with hemi-DIEP-flaps were intraoperatively evaluated with DIRT and LFA immediately after the completion and opening of the microvascular anastomosis.The recorded images from the different techniques were assesses in relation to clinical outcome.

.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Reconstructive Surgical Procedures

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Dynamic infrared thermography (DIRT) and indocyanine green fluorescence angiography (ICG-FA)

DIRT and ICG FA are used intraoperatively to evaluate perfusion of the perforators and the anastomosis. Both technique are compared in their ability to visualize perfusion.

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Post mastectomy.
* Previously breast cancer patent treated with radiation therapy.
* Breast implant reconstruction is not possible or undesired.
* Healthy patient with moderate amounts of abdominal skin laxity.
* Patient who requires a minimal to moderate volume breast reconstruction.
* The patient willing to undergo the long, complex procedure and prolonged postoperative recovery.
* The patient willing to accept an abdominal scar and a potential for donor site morbidities.
* Patients operated with prophylactic salpingo-oophorectomy due to BRCA gene mutation.

Exclusion Criteria

* Pregnancy and lactation.
* Patents below the age of 18 year.
* Renal failure or hepatic failure.
* Previous allergic reactions to ICG and iodide.
* Abdominal donor site that cannot be closed primarily.
* Previous TRAM flap or abdominoplasty.
* Significant medical comorbidities that make the patient a poor surgical candidate.
* Sigarette smoking or snuff.
* Obesity / BMI \> 30.
* Previous abdominal suction-assisted lipectomy.
Minimum Eligible Age

25 Years

Maximum Eligible Age

70 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

UiT The Arctic University of Norway

OTHER

Sponsor Role collaborator

University Hospital of North Norway

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Univesity Hospital of North Norway

Tromsø, , Norway

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Norway

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Louis de Weerd, MD, PhD,

Role: CONTACT

004777669793

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Louis de Weerd, MD, PhD

Role: primary

0047 77669793

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

22017/1641

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.